190 related articles for article (PubMed ID: 10385363)
1. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
Inada S; Koto T; Futami K; Arima S; Iwashita A
Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinoma.
Kaihara T; Kusaka T; Kawamata H; Oda Y; Fujii S; Morita K; Imura J; Fujimori T
Pathobiology; 2001; 69(3):172-8. PubMed ID: 11872963
[TBL] [Abstract][Full Text] [Related]
3. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
4. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract][Full Text] [Related]
6. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.
Natsugoe S; Uchikado Y; Okumura H; Matsumoto M; Setoyama T; Tamotsu K; Kita Y; Sakamoto A; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Mar; 17(3):517-23. PubMed ID: 17273727
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma.
Yoshida R; Morita M; Shoji F; Nakashima Y; Miura N; Yoshinaga K; Koga T; Tokunaga E; Saeki H; Oki E; Oda Y; Maehara Y
Ann Surg Oncol; 2015 Aug; 22(8):2608-14. PubMed ID: 25564163
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer.
Nakajima Y; Nagai K; Miyake S; Ohashi K; Kawano T; Iwai T
Jpn J Cancer Res; 2002 Mar; 93(3):305-12. PubMed ID: 11927013
[TBL] [Abstract][Full Text] [Related]
11. [Histopathological and immunohistochemical evaluation of lymph node metastasis in superficial esophageal cancer--with reference to the expression of E-cadherin and alpha-catenin].
Tamura S; Shiozaki H; Kadowaki T; Inoue M; Oka H; Matsui S; Mori T
Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):550-6. PubMed ID: 7565577
[TBL] [Abstract][Full Text] [Related]
12. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis.
Luo KJ; Hu Y; Wen J; Fu JH
J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261
[TBL] [Abstract][Full Text] [Related]
13. Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.
Uchikado Y; Natsugoe S; Okumura H; Setoyama T; Matsumoto M; Ishigami S; Aikou T
Clin Cancer Res; 2005 Feb; 11(3):1174-80. PubMed ID: 15709186
[TBL] [Abstract][Full Text] [Related]
14. Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Han U; Can OI; Han S; Kayhan B; Onal BU
Dis Esophagus; 2007; 20(5):379-85. PubMed ID: 17760650
[TBL] [Abstract][Full Text] [Related]
15. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakamoto A; Owaki T; Aikou T
J Exp Clin Cancer Res; 2009 Dec; 28(1):158. PubMed ID: 20025748
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
20. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]